Transitional Care Model Evaluation 2020
-
- STATUS
- Recruiting
-
- End date
- Jun 25, 2024
-
- participants needed
- 1600
-
- sponsor
- Mathematica Policy Research, Inc.
Summary
The study is a randomized controlled trial to estimate the effects of the transitional care model (TCM) on hospital admissions and patients' experience during the year following the patient's qualifying discharge. The University of Pennsylvania, where TCM was developed, will be the coordinating center for the implementation. The study will be conducted in four large health systems spread throughout the U.S., drawing patients from 9 hospitals in those systems. Eligible patients are older adults (age 65 and older) admitted to a participating hospital with symptoms of heart failure (HF), chronic obstructive pulmonary disease (COPD), or pneumonia (PNA). The evaluation will be conducted by Mathematica.
Description
The Transitional Care Model (TCM) is an advanced practice registered nurse (APRN) led, team-based, care management strategy designed to improve the care and outcomes of high-risk older adults transitioning from hospital to home. Eligible patients who agree to participate in the study will be randomly assigned to either the intervention group, which receives the TCM intervention, or the control group, which receives usual care (standard hospital discharge planning and post-hospital follow up services). The target sample size for the study is 1600, evenly divided into intervention and control groups, with 400 patients recruited from each of the 4 partnering health systems (Swedish, Trinity Health, University of California, San Francisco, and Veterans Health Administration (VHA) - St Louis and Cleveland). Data will be collected at intake, prior to randomization, by enrollment coordinators at each of the participating hospitals. Followup data will be collected in a survey of patients conducted 90 days after discharge, and from claims data obtained from Medicare, Medicare Advantage plans, and the VHA.
Details
| Condition | Pulmonary Disease, Lung Disease, Chronic Obstructive Lung Disease, COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Lung Disease, Heart failure, Congestive Heart Failure, Heart failure, Upper respiratory infection, Throat and Tonsil Infections, Pneumonia, Pneumonia, Pneumonia (Pediatric), Throat and Tonsil Infections, COPD (Chronic Obstructive Pulmonary Disease), Reactive Airway Disease, Pneumonia (Pediatric), Congestive Heart Failure, Lung Disease, chronic obstructive pulmonary disease, pneumoniae, pneumonitis, lung inflammation, COPD, chronic obstructive pulmonary disease (copd) |
|---|---|
| Treatment | Usual Care, Transitional care model (TCM) |
| Clinical Study Identifier | NCT04212962 |
| Sponsor | Mathematica Policy Research, Inc. |
| Last Modified on | 25 January 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer